Treasury Chief Rachel Reeves Intends Specific Action on Household Expenses in Forthcoming Budget
Treasury head Rachel Reeves has revealed she is preparing "specific action to deal with household expense pressures" in the forthcoming Budget.
Speaking to media outlets, she stated that curbing inflation is a shared duty of both the administration and the Bank of England.
The United Kingdom's price growth is expected to be the highest among the G7 advanced economies this year and next.
Possible Energy Bill Measures
Reports indicate the administration could take action to reduce energy bills, for example by slashing the present 5% level of VAT charged on energy supplies.
An additional possibility is to lower some of the policy costs presently included in household expenses.
Budgetary Constraints and Expert Predictions
The administration will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such measures.
The expectation from most analysts is that the Chancellor will have to announce tax increases or spending cuts in order to meet her declared debt limits.
Previously on the same day, analysis suggested there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of forecasts.
"It is a joint job between the central bank and the government to continue tackling some of the causes of inflation," Reeves stated to reporters in the US capital, at the annual meetings of the IMF and global financial institution.
Revenue Commitments and Global Issues
While much of the focus has been on likely tax rises, the Treasury chief said the latest information from the fiscal watchdog had not altered her vow to election pledges not to increase rates on income tax, sales tax or social security contributions.
She blamed an "uncertain world" with rising international and commercial issues for the Budget tax moves, likely to be focused on those "with the broadest shoulders."
International Trade Disputes
Addressing apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests invariably are paramount."
Last week's statement by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are key for high-technology manufacturing led American leader the US President to propose an further 100% import tax on goods from China, raising the risk of an all-out trade war between the two largest economies.
The American finance chief labeled the Chinese move "commercial pressure" and "a global supply chain power grab."
Inquired about considering the US offer to join its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."
She said the decision was "damaging for the world economy and causes further obstacles."
"It is my opinion there are areas where we need to confront Chinese policies, but there are also significant opportunities to sell into Chinese markets, including financial services and other sectors of the economy. We've got to maintain that balance right."
The chancellor also stated she was collaborating with international partners "on our own critical minerals approach, so that we are more independent."
NHS Medicine Costs and Investment
Reeves also recognized that the price the NHS pays for drugs could rise as a consequence of current discussions with the US government and its drugs companies, in return for reduced taxes and investment.
Some of the world's largest drug companies have said recently that they are either pausing or scrapping projects in the UK, with several blaming the low prices they are getting.
Recently, the government science advisor said the price the health service spends on medicines would have to rise to halt firms and drug research funding leaving the United Kingdom.
The Chancellor told the BBC: "It has been observed because of the pricing regime, that drug testing, new drugs have not been available in the United Kingdom in the manner that they are in other EU nations."
"We want to ensure that patients receiving care from the NHS are can access the best life-saving drugs in the globe. And so we are examining all of that, and... aiming to secure increased capital into the UK."